Cervical lymph nodes as a selective niche for brucella during oral infections

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Von Bargen, Kristine ^a,b   Gagnaire, Aurélie ^a,b   Arce Gorvel, Vilma ^a,b   De Bovis, Béatrice ^a,b   Baudimont, Fannie ^a,b   Chasson, Lionel ^a,b   Bosilkovski, Mile ^c   Papadopoulos, Alexia ^a,b   Martirosyan, Anna ^a,b   Henri, Sandrine ^a,b   Mège, Jean Louis ^d   Malissen, Bernard ^a,b   Gorvel, Jean Pierre ^a,b  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c University Clinic for Infectious Diseases and Febrile Conditions   (Macedonia)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; GRANZYME B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 12; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; CD68 ANTIGEN, HUMAN; CYTOKINE; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CARRIER; BRUCELLA; BRUCELLOSIS; CELL INFILTRATION; CERVICAL LYMPH NODE; CHILD; CONTROLLED STUDY; DAIRY PRODUCT; DISEASE SEVERITY; ENZYME INDUCTION; FEMALE; FOOD INTAKE; GRANULOMA; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; LYMPHADENOPATHY; LYMPHATIC DRAINAGE; MACEDONIA (REPUBLIC); MACROPHAGE MIGRATION; MAJOR CLINICAL STUDY; MIXED INFECTION; MONOCYTE; MOUSE; MOUTH INFECTION; NONHUMAN; PATHOPHYSIOLOGY; PRESCHOOL CHILD; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SCHOOL CHILD; UNIVERSITY HOSPITAL; ANIMAL; ANTIBODY SPECIFICITY; DISEASE MODEL; IMMUNOLOGY; LYMPH NODE; LYMPHATIC DISEASES; METABOLISM; MICROBIOLOGY; PATHOGENICITY; UTERINE CERVIX; ZOONOSIS;

ANIMALIA; BACTERIA (MICROORGANISMS); BRUCELLA; MURINAE; SALMONELLA TYPHIMURIUM;

ADOLESCENT; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRUCELLA; BRUCELLOSIS; CERVIX UTERI; CHILD; CHILD, PRESCHOOL; CYTOKINES; DAIRY PRODUCTS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC DISEASES; MACEDONIA (REPUBLIC); MICE; ORGAN SPECIFICITY; ZOONOSES;

EID: 84928639388     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0121790     Document Type: Article

References (66)

1. Dasaraju PV, Liu C. Infections of the Respiratory System. In: Baron S, editor. Medical Microbiology. 4th ed. Galveston (TX); 1996.
2. Yamazaki S, Maruyama A, Okada K, Matsumoto M, Morita A, et al. Dendritic cells from oral cavity induce Foxp3(+) regulatory T cells upon antigen stimulation. PLoS One 2012; 7: e51665. doi: 10.1371/journal.pone.0051665 PMID: 23272135
3. Hamrah P, Dana MR. Corneal antigen-presenting cells. Chem Immunol Allergy 2007; 92: 58-70. PMID: 17264483
4. Kida S, Pantazis A, Weller RO. CSF drains directly from the subarachnoid space into nasal lymphatics in the rat. Anatomy, histology and immunological significance. Neuropathol Appl Neurobiol 1993; 19: 480-488. PMID: 7510047
5. Wolvers DA, Coenen-de Roo CJ, Mebius RE, van der Cammen MJ, Tirion F, et al. Intranasally induced immunological tolerance is determined by characteristics of the draining lymph nodes: studies with OVA and human cartilage gp-39. J Immunol 1999; 162: 1994-1998. PMID: 9973470
6. Spahn TW, Weiner HL, Rennert PD, Lugering N, Fontana A, et al. Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. Eur J Immunol 2002; 32: 1109-1113. PMID: 11920578
7. Worbs T, Bode U, Yan S, Hoffmann MW, Hintzen G, et al. Oral tolerance originates in the intestinal immune system and relies on antigen carriage by dendritic cells. J Exp Med 2006; 203: 519-527. PMID: 16533884
8. van Helvoort JM, Samsom JN, Chantry D, Jansen W, Schadee-Eestermans I, et al. Preferential expression of IgG2b in nose draining cervical lymph nodes and its putative role in mucosal tolerance induction. Allergy 2004; 59: 1211-1218. PMID: 15461604
9. Corbel MJ. Brucellosis in Humans and Animals. WHO Press 2006.
10. Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, et al. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. PLoS medicine 2007; 4: e317. PMID: 18162038
11. Seleem MN, Boyle SM, Sriranganathan N. Brucellosis: a re-emerging zoonosis. Vet Microbiol 2010; 140: 392-398. doi: 10.1016/j.vetmic.2009.06.021 PMID: 19604656
12. Grillo MJ, Blasco JM, Gorvel JP, Moriyon I, Moreno E. What have we learned from brucellosis in the mouse model? Vet Res 2012; 43: 29. doi: 10.1186/1297-9716-43-29 PMID: 22500859
13. Tsou CL, Peters W, Si Y, Slaymaker S, Aslanian AM, et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007; 117: 902-909. PMID: 17364026
14. Forster R, Davalos-Misslitz AC, Rot A. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol 2008; 8: 362-371. doi: 10.1038/nri2297 PMID: 18379575
15. Hume DA. Applications of myeloid-specific promoters in transgenic mice support in vivo imaging and functional genomics but do not support the concept of distinct macrophage and dendritic cell lineages or roles in immunity. J Leukoc Biol 2011; 89: 525-538. doi: 10.1189/jlb.0810472 PMID: 21169519
16. McCabe RE, Brooks RG, Dorfman RF, Remington JS. Clinical spectrum in 107 cases of toxoplasmic lymphadenopathy. Rev Infect Dis 1987; 9: 754-774. PMID: 3326123
17. Golden MP, Vikram HR. Extrapulmonary tuberculosis: an overview. Am Fam Physician 2005; 72: 1761-1768. PMID: 16300038
18. Neelakantan S, Nair PP, Emmanuel RV, Agrawal K. Diversities in presentations of extrapulmonary tuberculosis. BMJ Case Rep 2013; 2013.
19. Gosche JR, Vick L. Acute, subacute, and chronic cervical lymphadenitis in children. Semin Pediatr Surg 2006; 15: 99-106. PMID: 16616313
20. Spink WW (1956) The Nature of Brucellosis: University of Minnesota Press.
21. Mousa AR, Elhag KM, Khogali M, Marafie AA. The nature of human brucellosis in Kuwait: study of 379 cases. Rev Infect Dis 1988; 10: 211-217. PMID: 3353631
22. Gur A, Geyik MF, Dikici B, Nas K, Cevik R, et al. Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey. Yonsei Med J 2003; 44: 33-44. PMID: 12619173
23. Yinnon AM, Morali GA, Goren A, Rudensky B, Isacsohn M, et al. Effect of age and duration of disease on the clinical manifestations of brucellosis. A study of 73 consecutive patients in Israel. Israel journal of medical sciences 1993; 29: 11-16. PMID: 8244674
24. Lulu AR, Araj GF, Khateeb MI, Mustafa MY, Yusuf AR, et al. Human brucellosis in Kuwait: a prospective study of 400 cases. Q J Med 1988; 66: 39-54. PMID: 3051080
25. Colmenero JD, Reguera JM, Martos F, Sanchez-De-Mora D, Delgado M, et al. Complications associated with Brucella melitensis infection: a study of 530 cases. Medicine (Baltimore) 1996; 75: 195-211. PMID: 8699960
26. Dokuzoguz B, Ergonul O, Baykam N, Esener H, Kilic S, et al. Characteristics of B. melitensis versus B. abortus bacteraemias. J Infect 2005; 50: 41-45. PMID: 15603839
27. Troy SB, Rickman LS, Davis CE. Brucellosis in San Diego: epidemiology and species-related differences in acute clinical presentations. Medicine 2005; 84: 174-187. PMID: 15879907
28. Plommet M. Studies on Experimental Brucellosis in Cows in France; 1977.
29. Plommet M, Plommet AM. Vaccination against bovine brucellosis with a low dose of strain 19 administered by the conjunctival route. Ann Rech Vet 1976; 7: 1-8. PMID: 825014
30. McCullough NB (1970) Microbial and host factors in the pathogenesis of brucellosis. Infectious Agents and Host Reactions. pp. 324-345.
31. Kastenmuller W, Torabi-Parizi P, Subramanian N, Lammermann T, Germain RN. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 2012; 150: 1235-1248. doi: 10.1016/j.cell.2012.07.021 PMID: 22980983
32. Monack DM, Bouley DM, Falkow S. Salmonella typhimurium persists within macrophages in the mesenteric lymph nodes of chronically infected Nramp1+/+ mice and can be reactivated by IFNgamma neutralization. J Exp Med 2004; 199: 231-241. PMID: 14734525
33. Murphy EA, Sathiyaseelan J, Parent MA, Zou B, Baldwin CL. Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice. Immunology 2001; 103: 511-518. PMID: 11529943
34. Corthesy-Theulaz IE, Hopkins S, Bachmann D, Saldinger PF, Porta N, et al. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun 1998; 66: 581-586. PMID: 9453612
35. Bonneau M, Epardaud M, Payot F, Niborski V, Thoulouze MI, et al. Migratory monocytes and granulocytes are major lymphatic carriers of Salmonella from tissue to draining lymph node. J Leukoc Biol 2006; 79: 268-276. PMID: 16330534
36. Eze MO, Yuan L, Crawford RM, Paranavitana CM, Hadfield TL, et al. Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro. Infect Immun 2000; 68: 257-263. PMID: 10603396
37. Jiang X, Leonard B, Benson R, Baldwin CL. Macrophage control of Brucella abortus: role of reactive oxygen intermediates and nitric oxide. Cell Immunol 1993; 151: 309-319. PMID: 8402938
38. Jones SM, Winter AJ. Survival of virulent and attenuated strains of Brucella abortus in normal and gamma interferon-activated murine peritoneal macrophages. Infect Immun 1992; 60: 3011-3014. PMID: 1612769
39. Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 2012; 12: 352-366. doi: 10.1038/nri3211 PMID: 22517424
40. Zumla A, James DG. Granulomatous infections: etiology and classification. Clin Infect Dis 1996; 23: 146-158. PMID: 8816144
41. Copin R, Vitry MA, Hanot Mambres D, Machelart A, De Trez C, et al. In situ microscopy analysis reveals local innate immune response developed around Brucella infected cells in resistant and susceptible mice. PLoS Pathog 2012; 8: e1002575. doi: 10.1371/journal.ppat.1002575 PMID: 22479178
42. Eskra L, Mathison A, Splitter G. Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus. Infect Immun 2003; 71: 1125-1133. PMID: 12595423
43. Gross A, Spiesser S, Terraza A, Rouot B, Caron E, et al. Expression and bactericidal activity of nitric oxide synthase in Brucella suis-infected murine macrophages. Infect Immun 1998; 66: 1309-1316. PMID: 9529047
44. Zhan Y, Liu Z, Cheers C. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun 1996; 64: 2782-2786. PMID: 8698508
45. Caron E, Peyrard T, Kohler S, Cabane S, Liautard JP, et al. Live Brucella spp. fail to induce tumor necrosis factor alpha excretion upon infection of U937-derived phagocytes. Infect Immun 1994; 62: 5267-5274. PMID: 7960104
46. Barquero-Calvo E, Chaves-Olarte E, Weiss DS, Guzman-Verri C, Chacon-Diaz C, et al. Brucella abortus uses a stealthy strategy to avoid activation of the innate immune system during the onset of infection. PLoS One 2007; 2: e631. PMID: 17637846
47. Netea MG, Kullberg BJ, Verschueren I, Van Der Meer JW. Interleukin-18 induces production of proinflammatory cytokines in mice: no intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta. Eur J Immunol 2000; 30: 3057-3060. PMID: 11069090
48. Fernandez-Lago L, Orduna A, Vizcaino N. Reduced interleukin-18 secretion in Brucella abortus 2308-infected murine peritoneal macrophages and in spleen cells obtained from B. abortus 2308-infected mice. J Med Microbiol 2005; 54: 527-531. PMID: 15888459
49. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011; 11: 723-737. doi: 10.1038/nri3073 PMID: 21997792
50. Paixao TA, Roux CM, den Hartigh AB, Sankaran-Walters S, Dandekar S, et al. Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen. Infect Immun 2009; 77: 4197-4208. doi: 10.1128/IAI.00417-09 PMID: 19651862
51. Gorvel JP, Moreno E, Moriyon I. Is Brucella an enteric pathogen? Nat Rev Microbiol 2009; 7: 250; author reply 250. doi: 10.1038/nrmicro1932-c3 PMID: 19230236
52. Lee JJ, Kim DH, Park SB, Lim JJ, Kim DG, et al. Redundant effects of ketamine on the pathogenesis and severity of Brucella abortus infection. Comparative immunology, microbiology and infectious diseases 2012.
53. Nunes-Alves C, Nobrega C, Behar SM, Correia-Neves M. Tolerance has its limits: how the thymus copes with infection. Trends Immunol 2013; 34: 502-510. doi: 10.1016/j.it.2013.06.004 PMID: 23871487
54. Nobrega C, Cardona PJ, Roque S, Pinto do OP, Appelberg R, et al. The thymus as a target for mycobacterial infections. Microbes Infect 2007; 9: 1521-1529. PMID: 18062904
55. Tessaro SV, Forbes LB. Experimental Brucella abortus infection in wolves. J Wildl Dis 2004; 40: 60-65. PMID: 15137489
56. Nobrega C, Roque S, Nunes-Alves C, Coelho A, Medeiros I, et al. Dissemination of mycobacteria to the thymus renders newly generated T cells tolerant to the invading pathogen. J Immunol 2010; 184: 351-358. doi: 10.4049/jimmunol.0902152 PMID: 19949112
57. Fletcher AL, Malhotra D, Acton SE, Lukacs-Kornek V, Bellemare-Pelletier A, et al. Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells. Front Immunol 2011; 2: 35. doi: 10.3389/fimmu.2011.00035 PMID: 22566825
58. Hammerschmidt SI, Ahrendt M, Bode U, Wahl B, Kremmer E, et al. Stromal mesenteric lymph node cells are essential for the generation of gut-homing T cells in vivo. J Exp Med 2008; 205: 2483-2490. doi: 10.1084/jem.20080039 PMID: 18852290
59. Fugier E, Salcedo SP, de Chastellier C, Pophillat M, Muller A, et al. The glyceraldehyde-3-phosphate dehydrogenase and the small GTPase Rab 2 are crucial for Brucella replication. PLoS Pathog 2009; 5: e1000487. doi: 10.1371/journal.ppat.1000487 PMID: 19557163
60. Celli J, de Chastellier C, Franchini DM, Pizarro-Cerda J, Moreno E, et al. Brucella evades macrophage killing via VirB-dependent sustained interactions with the endoplasmic reticulum. J Exp Med 2003; 198: 545-556. PMID: 12925673
61. Wray C, Sojka WJ. Experimental Salmonella typhimurium infection in calves. Research in veterinary science 1978; 25: 139-143. PMID: 364573
62. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr., et al. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997; 100: 2552-2561. PMID: 9366570
63. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999; 99: 23-33. PMID: 10520991
64. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 2005; 22: 643-654. PMID: 15894281
65. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, et al. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 2002; 17: 211-220. PMID: 12196292
66. Van den Broeck W, Derore A, Simoens P. Anatomy and nomenclature of murine lymph nodes: Descriptive study and nomenclatory standardization in BALB/cAnNCrl mice. J Immunol Methods 2006; 312: 12-19. PMID: 16624319